Although this study provides robust evidence supporting the role of CD73/ADO signalling in mediating the immunosuppressive and anti‐osteolytic effects of RATEVs on CD4+ T lymphocytes and alveolar bone loss in experimental periodontitis, several key questions remain unanswered. The gene discussed is ADO; the disease is periodontitis.